Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillipp Torkler

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
World Journal of Urology|January 27, 2022
Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcomeAlexander Kretschmer, Ronald Tutrone, Jason Alter, et al.
Molecular Cell|March 21, 2017
Genome-wide Analysis of RNA Polymerase II Termination at Protein-Coding GenesCarlo Baejen, Jessica Andreani, Phillipp Torkler, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2021
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studiesErik Margolis, Gordon Brown, Alan Partin, et al.
European Urology|September 22, 2018
A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial BiopsyJames McKiernan, Michael J Donovan, Eric Margolis, et al.
Scientific Reports|March 22, 2022
Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsyAlexander Kretschmer, Holger Kajau, Eric Margolis, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
World Journal of Urology|January 27, 2022
Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcomeAlexander Kretschmer, Ronald Tutrone, Jason Alter, et al.
Molecular Cell|March 21, 2017
Genome-wide Analysis of RNA Polymerase II Termination at Protein-Coding GenesCarlo Baejen, Jessica Andreani, Phillipp Torkler, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2021
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studiesErik Margolis, Gordon Brown, Alan Partin, et al.
European Urology|September 22, 2018
A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial BiopsyJames McKiernan, Michael J Donovan, Eric Margolis, et al.
Scientific Reports|March 22, 2022
Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsyAlexander Kretschmer, Holger Kajau, Eric Margolis, et al.
Pageof 2